Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients
- 1 May 1993
- journal article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 19 (5) , 265-272
- https://doi.org/10.1007/bf01690546
Abstract
To determine admission characteristics associated with the outcome of septicemia in critically ill patients and more specifically assess the prognostic value of pre-existing co-morbidities. 5 year-retrospective cohort study. Surgical Intensive Care Unit (ICU-20 beds) in a 1600 bed-tertiary care center. Among 5457 patients admitted to the ICU between 1984 and 1988, 176 (3.2%) met prospectively-defined criteria for blood culture-proven septicemia (8.77 per 1000 patient-days). Overall septicemic patients had a 5-fold increased risk of death compared to non-septicemic patients (relative risk 5.03, 95% confidence intervals 4.17–6.07,p<0.0001), and this estimate persisted after stratification according to age, sex, primary diagnosis and conditions of admission to the ICU (emergency/elective). Prognostic factors recorded on admission to ICU that were associated with mortality from septicemia among 173 patients were older age, higher admission Apache II score, gastrointestinal surgery, ultimately and rapidly fatal diseases and the number of co-morbidities in addition to the principal diagnosis (active smoking, alcohol abuse, non-cured malignancy, diabetes mellitus, splenectomy, recent antibiotic therapy, major surgery, or major cardiac event). In the multivariate analysis with logistic regression procedures, Apache II and co-morbidities were identified as the two independent predictors of mortality. Pre-existing co-morbidities assessed at the admission to the ICU significantly improved the prediction of mortality from septicemia compared to Apache II score alone.Keywords
This publication has 44 references indexed in Scilit:
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospitalThe American Journal of Medicine, 1991
- A Three-Year Study of Positive Blood Cultures, with Emphasis on PrognosisClinical Infectious Diseases, 1990
- Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized TrialThe Journal of Infectious Diseases, 1988
- Financial Risk, Hospital Cost, Complications, and Comorbidities in Surgical Noncomplication- and Noncomorbidity-stratified Diagnostic Related GroupsAnnals of Surgery, 1988
- APACHE IICritical Care Medicine, 1985
- The value of measuring severity of disease in clinical research on acutely ill patientsJournal of Chronic Diseases, 1984
- A COMPARISON OF INTENSIVE CARE IN THE U.S.A. AND FRANCEThe Lancet, 1982
- Nosocomial infections in intensive care wards: A multicenter prospective studyIntensive Care Medicine, 1982
- APACHE—acute physiology and chronic health evaluation: a physiologically based classification systemCritical Care Medicine, 1981